Skip to main content

Table 8 Outcomes for ATX assay in spiked plasma

From: Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis

Conc. level (ng/mL)

Recovery*± SD

200

98.55 ± 2.11

500

97.83 ± 1.35

900

98.83 ± 1.01

1000

97.63 ± 1.35

  1. *Mean of three ATX replicate measurements, SD = Standard deviation
Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us